CT
JAZZ icon

Clearstead Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Clearstead Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Hold
63
– – ﹤0.01% 523
2026
Q1 		$11.9K Hold
63
– – ﹤0.01% 534
2025
Q4 		$10.7K Buy
63
+2
+3% +$307 ﹤0.01% 574
2025
Q3 		$8.04K Sell
61
-2
-3% -$240 ﹤0.01% 645
2025
Q2 		$6.69K Buy
63
+57
+950% +$6.19K ﹤0.01% 683
2025
Q1 		$745 Buy
+6
New +$783 ﹤0.01% 843

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Clearstead Trust's JAZZ Position: Q2 2026 in Review

Clearstead Trust held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 63 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Clearstead Trust first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Clearstead Trust held 63 shares of Jazz Pharmaceuticals worth $15.2K as of Q2 2026.
  • Clearstead Trust left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #523 holding.
  • Clearstead Trust first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.